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Dermal Blimp1 Acts Downstream of
Epidermal TGFb and Wnt/b-Catenin
to Regulate Hair Follicle Formation
and Growth
Stephanie B. Telerman1,3, Emanuel Rognoni1,3, Ineˆs Sequeira1, Angela Oliveira Pisco1,
Beate M. Lichtenberger2, Oliver J. Culley1, Priyalakshmi Viswanathan1, Ryan R. Driskell1 and
Fiona M. Watt1
B-lymphocyte-induced maturation protein 1 (Blimp1) is a transcriptional repressor that regulates cell growth
and differentiation in multiple tissues, including skin. Although in the epidermis Blimp1 is important for ker-
atinocyte and sebocyte differentiation, its role in dermal fibroblasts is unclear. Here we show that Blimp1 is
dynamically regulated in dermal papilla cells during hair follicle (HF) morphogenesis and the postnatal hair
cycle, preceding dermal Wnt/b-catenin activation. Blimp1 ablation in E12.5 mouse dermal fibroblasts delayed HF
morphogenesis and growth and prevented new HF formation after wounding. By combining targeted quan-
titative PCR screens with bioinformatic analysis and experimental validation we demonstrated that Blimp1 is
both a target and a mediator of key dermal papilla inductive signaling pathways including transforming growth
factor-b and Wnt/b-catenin. Epidermal overexpression of stabilized b-catenin was able to override the HF de-
fects in Blimp1 mutant mice, underlining the close reciprocal relationship between the dermal papilla and
adjacent HF epithelial cells. Overall, our study reveals the functional role of Blimp1 in promoting the dermal
papilla inductive signaling cascade that initiates HF growth.
Journal of Investigative Dermatology (2017) 137, 2270e2281; doi:10.1016/j.jid.2017.06.015
INTRODUCTION
B-lymphocyte-induced maturation protein 1 (Blimp1; Prdm1)
is a zinc finger transcription factor that is first expressed at
mouse embryonic (E) day 6.25 of development, and mice
lacking Blimp1 die at E10.5 due to placental insufficiency
(Vincent et al., 2005). Within mouse skin, Blimp1 is highly
expressed from E16.5 in developing hair follicles (HFs),
sebaceous glands, and interfollicular epidermis (Chang and
Calame, 2002). Epidermal deletion of Blimp1 causes multi-
ple differentiation defects (Kretzschmar et al., 2014),
including interfollicular epidermal hyperplasia (Chiang et al.,
2013), sebaceous gland enlargement (Horsley et al., 2006),
and impaired epidermal barrier formation (Magnu´sdo´ttir
et al., 2007). One of the underlying molecular mechanisms
is Blimp1-mediated repression of c-Myc (Horsley et al., 2006;
Kretzschmar et al., 2014; Lin et al., 1997).
In the dermis, Blimp1 is first expressed at E14.5 in the
condensates of fibroblasts that will form the HF dermal
papilla (DP) (Lesko et al., 2013; Robertson et al., 2007).
Blimp1þ cells give rise to the DP, dermal sheath, arrector pili
muscles, and the papillary fibroblasts that are required for HF
neogenesis during wound healing (Driskell et al., 2013;
Lesko et al., 2013; Robertson et al., 2007). Furthermore,
when Blimp1 is deleted in Sox2þ cells, whiskers do not
develop (Robertson et al., 2007).
Given the importance of Blimp1 in regulating differentia-
tion in a wide range of cell types, we have investigated the
effects of dermal-specific Blimp1 deletion on skin homeo-
stasis and wound healing. Our findings demonstrate that
Blimp1 is induced by transforming growth factor-b (TGFb)
and controls dermal Wnt/b-catenin signaling, identifying
Blimp1 as a core transcriptional regulator of DP activity
during HF growth initiation.
RESULTS
Dynamic expression of Blimp1 in the DP
We first performed a characterization of Blimp1 expression
during HF morphogenesis and the hair cycle (HC). Blimp1
was expressed at the earliest stage (stage 0) of HF develop-
ment (Paus et al., 1999) in PDGFRaþ fibroblasts underlying
the epidermal thickening that precedes dermal condensate
formation (Figure 1a). Blimp1 was expressed in all dermal
condensates (stage 1), the dermal placodes (stages 2 and 3),
and developing (stage 4) and mature DPs (stages 5 and 6),
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regardless of HF type. Blimp1 expression was progressively
lost from the DP at stages 7 and 8. Blimp1 began to be
expressed in differentiating HF matrix epithelial cells at
stages 5 and 6 (Figure 1a). In dermal condensate fibroblasts,
Blimp1 expression correlated with the early placode marker
Lef1 (Figure 1b; Kratochwil et al., 1996). However, Lef1
expression persisted in the DP at later HF stages, whereas
Blimp1 expression did not (Figure 1b).
To correlate Blimp1 expression with active Wnt/b-catenin
signaling, we examined transgenic Wnt reporter HFs
(TOPGFP; Ferrer-Vaquer et al., 2010). Blimp1 expression
preceded b-catenin signaling activation in DP fibroblasts,
because TOPGFP was only observed after stage 1, in agree-
ment with earlier studies (Tsai et al., 2014). At stages 7 and 8,
TOPGFP activity remained high in the DP, consistent with
Lef1 expression, whereas Blimp1 expression was lost
(Figure 1b, 1c).
In adults, Blimp1 was not expressed during HC catagen or
telogen stages. However, Blimp1 was expressed in DP cells
during anagen induction (P22eP23) (Figure 1d, 1e),
remained high during early and advanced anagen, and was
lost in late anagen (Figure 1d). Similarly, Blimp1 expression
preceded TOPGFP activation in the DP, which remained high
at advanced anagen, when Blimp1 expression started to
decrease (Figure 1f). In human skin, Blimp1 expression was
restricted to placodes and absent in full anagen DP cells
(Figure 1g, 1h).
We conclude that Blimp1 is an early placode marker in
human and mouse skin, where it precedes Wnt signaling
activation. In the DP, Blimp1 is downregulated in late HF
anagen and re-expressed during anagen induction (Figure 1i).
Dermis-specific Blimp1 deletion delays HF morphogenesis
and anagen onset
Next, we generated a dermis-specific conditional Blimp1
knockout (Blimp1(dKO)), by crossing Prdm1flox/flox mice
with Dermo1Cre transgenics (Supplementary Table S1 on-
line, Figure 2a, 2b). Successful dermis-specific Blimp1 dele-
tion was confirmed by antibody labeling, with only scattered
Blimp1þ dermal cells detected in Blimp1(dKO) skin
(Figure 2c). At P2, Blimp1(dKO) mice were distinguished
from littermate controls by the pale coloration of the back
skin and forehead. By P21, the hair coat had developed but
was sparser than in controls and whisker development was
delayed (Figure 2b, Supplementary Figure S1a online).
All fibroblast subpopulations were present in the P2
dermis and the arrector pili muscle differentiated normally
(Figure 2d). There was a small, but statistically significant,
Figure 1. Blimp1 is dynamically expressed in DP during HF morphogenesis and postnatal anagen induction. (aec) Blimp1 expression during HF
morphogenesis. Skin sections from PDGFRaH2BeGFP mice immunostained for (a) GFP and Blimp1 or (b) Lef1 and Blimp1. (c) TOPGFP back skin sections
immunolabeled for GFP and Blimp1. (def) Blimp1 expression during postnatal HC. (d, e) Immunostaining of adult back skin for PDGFRa and Blimp1 at
the indicated age or HC stage. (f) TOPGFP skin sections immunolabeled for GFPand Blimp1 at the indicated HC stage. (g) Immunostaining of human embryonic
skin (week 13) for Krt14 and Blimp1. Early (asterisk), middle (arrow), and late (arrowhead) placode formation stage. (h) Adult human HF was immunostained
for Lef1 and Blimp1. (i) Schematic summary of Blimp1 expression and TOPGFP activity in dermal fibroblasts and keratinocytes during HF development.
Scale bars ¼ 50 mm (aef), 100 mm (g, h). A, anagen; Blimp1, B-lymphocyte-induced maturation protein 1; DP, dermal papilla; HC, hair cycle; HF, hair follicle;
Mx, HF matrix.
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Figure 2. Specific deletion of Blimp1 in the dermis leads to HF growth retardation and decrease in the papillary fibroblast subpopulation. (a) Breeding
strategy. (b) Mice at the indicated postnatal ages. (c) Immunofluorescence staining for PDGFRa and Blimp1 of P2 skin. DP (arrowhead); single Blimp1þ DP cells
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reduction in papillary fibroblasts (CD26þ,Sca1). Howev-
er, there was no change in other fibroblast populations,
including DP cells (Figure 2def, Supplementary
Figure S1b).
Total dermal cell density and proliferation were not
significantly affected by Blimp1 deletion (Figure 2g, 2h,
Supplementary Figure S1c). However, the P2 dermis was
thinner in Blimp1(dKO) mice (Figure 2i), which probably
reflects the delay in hair coat development (Figure 2b).
Dermal Blimp1 deletion did not alter HF density and
spacing after HF morphogenesis or postnatal HCs
(Supplementary Figure S2a, S2b online). Blimp1(dKO) HFs
were shorter at P8, but catagen induction was not delayed at
P16, indicating that the hair growth phase was shortened on
Blimp1 deletion (Supplementary Figure S2c, S2d). The tel-
ogen to anagen transition was delayed as Blimp1(dKO) HFs
failed to enter anagen at P23 (Figure 2j, 2k). By P30,
Blimp1(dKO) HFs were all in anagen; they also transitioned
through catagen and telogen normally, pointing to a short-
ened HF growth phase. Both control and Blimp1(dKO) HFs
entered the asynchronous HC phase after P80
(Supplementary Figure S2c). The anagen induction defect
was also observed in adult Blimp1(dKO) after depilation as
HFs were shorter and the dermis was thinner than in controls
(Figure 2len, Supplementary Figure S2e).
In summary, although Blimp1 is not required for the
development of the papillary lineages, including the DP, it
does influence the number of papillary fibroblasts. Besides,
in the absence of Blimp1, both HF morphogenesis and
anagen are delayed, resulting in a shorter HF growth
phase.
Dermal Blimp1 ablation alters HF maturation and type
The mouse coat consists of four different HF types that arise
in three consecutive waves during development (Chi et al.,
2013; Schlake, 2007; Tsai et al., 2014). All HF types were
present in Blimp1(dKO) skin, but zigzag HFs were thinner
and smaller (Figure 3aec, Supplementary Figure S3a online).
Furthermore, the number of awl and auchene HFs was
decreased, whereas zigzag HFs were significantly increased
(Figure 3d). Although awl3 HF size was not altered, Blimp1
deletion resulted in aberrant medulla cell organization: the
medulla area was significantly reduced and cells failed to
align in triplicates (Figure 3eeg). In contrast, medulla cell
organization in guard HFs was not affected (Supplementary
Figure S3b, S3c).
To examine the effect of dermal Blimp1 deletion on
epidermal cells that are juxtaposed to the DP (Legue´ and
Nicolas, 2005), we labeled hair bulb cells for P-cadherin
and measured 5-ethynyl-2’-deoxyuridine (EdU) incorporation
in anagen (Figure 3h, 3i, Supplementary Figure S3d).
Although HF matrix cell organization showed no obvious
defects, the number of EdUþ cells was significantly reduced
in Blimp1(dKO) HFs.
We conclude that dermal Blimp1 ablation impairs HF
matrix cell proliferation in all HF types. We suggest
that the decreased HF matrix cell proliferation could ac-
count for the awl3 medulla cell disorganization and the
changes in zigzag number and size on dermal Blimp1
deletion, two defects associated with perturbations in DP
cell number or signaling (Chi et al., 2013; Enshell-Seijffers
et al., 2010).
Dermal Blimp1 deletion impairs skin regeneration
We next analyzed the ability of Blimp1-depleted dermis to
repair full thickness wounds and to regenerate HFs. At post-
wounding day 7, Blimp1(dKO) wounds were larger than
controls (Figure 4a, 4b). Although the control wound beds
showed new HFs at postwounding day 7, HF formation was
significantly reduced in Blimp1-depleted wounds and at
postwounding day 14 only a few immature HFs were
observed (Figure 4c, 4d). The HF formation defect did not
correlate with changes in wound bed cell density or prolif-
eration (Figure 4e, 4f).
To confirm that Blimp1 is normally expressed in newly
forming HFs, we examined wounds in Blimp1GFP reporter
mice. At postwounding day 7, there was strong GFP
expression in the developing HF placodes (Figure 4g). In
adult wounds, which do not regenerate HFs (Rognoni
et al., 2016), Blimp1 was not expressed in the wound
bed dermis (Figure 4h). We conclude that although Blimp1
is not required for HF formation during development,
Blimp1 is important for HF regeneration in neonatal
wounds.
Blimp1 is associated with core DP signaling pathways,
including TGFb and Wnt/b-catenin
Employing a bioinformatic pipeline, we generated a broad
DP lineage signature consisting of 8,588 genes and inter-
sected that with a list of pan-Blimp1 target genes comprising
7,196 entities, compiled from different published screens
(Figure 5a). Of 8,588 DP entities, 2,078 are known to be
regulated by Blimp1 and are associated with GO terms such
as “Cellular Growth and Proliferation” and “Cellular Devel-
opment” (Figure 5b). Using the GSEA MGSig Database to
mine canonical signaling pathways we found that the DP/
Blimp1-regulated entities are strongly associated with growth
factor (GF) pathways as well as mitogen-activated protein
kinase and Wnt signaling (Figure 5c).
To validate the bioinformatics predictions we flow sorted
CD140aþ,CD133þ DP cells from P2 control and
Blimp1(dKO) dorsal skin and performed quantitative PCR
(qPCR) analysis using a reverse transcriptase-PCR array to
detect expression of a panel of GFs and Wnt/b-catenin target
genes (Figure 5d, 5g). Of 60 GFs analyzed, 80% were
(asterisk). (d) P2 skin immunostaining for Lrig1 and Sca1 (upper panel), DLK1 and aSMA (lower panel). The white dashed line indicates boundaries of papillary
(Pap), reticular (Ret) dermis, and dermal white adipose tissue (DWAT). (e) Fibroblast subpopulation FACS analysis and quantification. (f) FACS quantification
of DP cells as percent of total fibroblasts. (g) Immunostaining for Ki67 and Itga6 of P2 skin and (h) quantification. (i) Dermal thickness quantification at P1.
(j) H&E-stained skin sections at P23. (k) Percentage of HFs in anagen at P23, P28, and P30. (len) Analysis of depilation induced anagen induction. (l)
Immunostaining of skin 10 days post depilation (PD10) for Lef1 and Krt-14. Quantification of (m) HF length and (n) dermis thickness at PD10. Data shown
are means  standard deviation. *P< 0.05, **P< 0.005, ***P< 0.0005. Scale bars ¼ 100 mm. Blimp1, B-lymphocyte-induced maturation protein 1; DP, dermal
papilla; H&E, hematoxylin and eosin; HF, hair follicle; ns, not significant.
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Figure 3. Dermal Blimp1 ablation
impairs the HF maturation process
leading to changes in HF size,
thickness, type, and medulla cell
organization. (a) Bright field images of
HF types at P60 and (b) quantification
of HF length (upper panel) and
thickness (lower panel). (c) HF type
bright field close-up at P60. (d) HF
type quantification at P11. (e) Bright
field image of microdissected awl3 HF
(left panel) and HF transversal
semithin section. The black bar
indicates the region of the HF cross
section shown in the right panel. (f, g)
Quantification of medulla cell (f) area
and (g) alignment in awl3 HF cross
sections. (h) EdU labeling of P11 back
skin sections immunostained for Itga6
and (i) quantification. Data shown are
means  standard deviation. *P <
0.05, ***P < 0.0005. Scale bars ¼ 20
mm (c), 25 mm (e), 50 mm (h). Blimp1,
B-lymphocyte-induced maturation
protein 1; Co, cortex; Cu, cuticle;
EdU, 5-ethynyl-2’-deoxyuridine; He,
Henle layer; HF, hair follicle; Hu,
Huxley layer; IRS, inner root sheet; M,
medulla; ns, not significant; ORS,
outer root sheath.
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downregulated in Blimp1(dKO) DP cells, 24 significantly
(fold change > 2) (Figure 5d). These included several well-
known DP signaling factors of the bone morphogenic pro-
tein (BMP)/TGFb and fibroblast growth factor (FGF) families,
including BMP4/6/7/8 and FGF8 and FGF18 (Lee and
Tumbar, 2012; Sennett and Rendl, 2012). In the Wnt
signaling screen, 34 of 45 genes (76%) were reduced in
expression, 22 significantly (fold change > 2) (Figure 5g).
These genes were strongly associated with canonical Wnt
signaling, such as Lef1, Wnt9a, PTCH1, and FZD7, whereas
expression of noncanonical Wnt signaling genes such as
Wnt5a was increased (Figure 5g).
We next intersected the differentially expressed genes of
both qPCR screens with the pan-Blimp1 and DP signatures
and represented each intersection using Ingenuity Pathway
Analysis annotated interactions, allowing us to highlight the
connections between different nodes and Blimp1
(Figure 5e, 5f, 5h, 5i). We identified 18 DP genes potentially
regulated by Blimp1 in the GF screen (Figure 5e) and
confidently connected 9 of 14 hits, with TGFb1 in the
center of the network (Figure 5f). In the case of Wnt
signaling, we identified 17 DP genes potentially regulated
by Blimp1 (Figure 5h) with b-catenin as a connecting entity,
which was added to the network and allowed connection of
15 of 16 hits (Figure 5i). As expected, Myc was significantly
upregulated in Blimp1 deleted DP cells and was identified
as being directly repressed by Blimp1 (Figure 5g, 5i).
Intriguingly, the predictions for molecular activity in both
resulting Ingenuity Pathway Analysis networks anticipated
strong Blimp1 inhibition, supporting the qPCR screen results
(Figure 5f, 5i).
Next, by performing a core analysis in Ingenuity Pathway
Analysis we identified potential upstream Blimp1 regulators.
The most prominent putative regulator was TGFb1, with
TNFa, FGF2, IGF, Wnt effector CTNNB1 (b-catenin), SHH,
and EGF also represented (Figure 6a). We tested the effects of
candidate GFs on primary CD140aþ,CD133þ DP cells
(Figure 6b). TGFb2, EGF, and BMP4 significantly increased
Blimp1 expression, whereas TNFa, PDGF-BB, and FGF2 had
no effect and SHH significantly reduced Blimp1 expression.
TGFb2 also induced Blimp1 expression in unfractionated
cultured mouse fibroblasts (Supplementary Figure S4 online),
whereas TGFb1 and TGFb2 induced Blimp1 in primary hu-
man dermal fibroblasts (Figure 6c). The response to SHH was,
however, restricted to DP cells (Figure 6b, 6c, Supplementary
Figure S4).
To determine whether Blimp1 loss would reduce dermal
Wnt/b-catenin signaling activity, we crossed Blimp1(dKO)
with TOPGFP mice and quantified TOPGFPþ cells
(Figure 6deg). As previously shown (Rognoni et al., 2016),
Wnt signaling was highly active in papillary, dermal sheath,
and DP cells of control mice (Figure 6d). In Blimp1(dKO) skin,
the number of TOPGFPþ fibroblasts was significantly
decreased, both in unfractionated fibroblasts and DP cells
(Figure 6eeg). Consistently, nuclear accumulation of Lef1,
TCF1, TCF4, and active b-catenin in Blimp1(dKO) anagen DP
Figure 4. Effect of dermal Blimp1 deletion on skin regeneration in neonatal wounds. (a) Picture of P2 wounded mice at PW7 (upper panel). The lower panel
shows a close-up of boxed wound areas in the upper panel. (b) PW7 wound area quantification. (c) Immunostaining of PW7 and PW14 wound beds for
Itga6 and Ki67. Arrowheads indicate new HFs and the asterisk indicates unspecific Ki67 staining in the lower wound bed. (def) Quantification of (d) new HFs
per wound bed, (e) Ki67þ dermal cells in the wound bed area, and (f) dermal cells in the wound bed area at PW7 and PW14. (g) PW7 neonatal wound
immunostained for Itga6 and GFP in Blimp1GFP reporter mice. The arrowhead indicates high GFP expression around new forming HFs. (h) Immunostaining
for PDGFRa and Blimp1 10 days after wounding P21 old mice. Data shown are means  standard deviation. *P < 0.05, ***P < 0.0005. Scale bars ¼ 50 mm
(g), 100 mm (h). Blimp1, B-lymphocyte-induced maturation protein 1; HF, hair follicle; PW, postwounding.
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cells was reduced and therewas a decrease in Sox2 expression
in awl, auchene, and guard HFs (Supplementary Figure S5a,
S5b online). The reduced Sox2 expression could be an indirect
effect of attenuated core DP signaling activity or a direct
consequence of loss of Blimp1 transcriptional activity as
shown in other tissues (Kurimoto et al. 2008).
Thus, by combining targeted qPCR screens, bioinformatic
analysis, and in vivo validation, we identified Blimp1 as both
Figure 5. Dissecting the Blimp1 signaling network in the DP. (a) DP signature and pan-Blimp1 target genes Venn diagram. (b) GO term and (c) GSEA pathway
analysis of intersected Blimp1-regulated DP genes in (a). (def) Identifying Blimp1-regulated GFs. (d) Gene expression heatmap of the DP cell GF qPCR screen.
(e) Venn diagram intersecting differentially expressed GFs with DP signature and pan-Blimp1 target genes. (f) Ingenuity Pathway Analysis of differentially
expressed GFs in the DP. (gei) Identifying Blimp1-regulated Wnt/b-catenin signaling networks. (g) Gene expression heatmap of DP cell Wnt signaling qPCR. (h)
Venn diagram intersecting differentially expressed Wnt signaling genes with DP signature and pan-Blimp1 target genes. (i) Ingenuity Pathway Analysis of
differentially expressed Blimp1-regulated Wnt signaling genes in the DP. Note that in both identified networks (f, i) Blimp1 is predicted to be downregulated.
Solid lines indicate direct and dashed lines indirect interactions. Color intensities reflect average gene expression log2-fold change. Blimp1, B-lymphocyte-
induced maturation protein 1; DP, dermal papilla; GF, growth factor; qPCR, quantitative PCR.
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a target and central mediator of DP inductive signaling path-
ways, including FGF, Wnt/b-catenin, and TGFb/BMP. The HF
defects resulting from Blimp1 deletion are likely to be due, at
least in part, to downregulation of b-catenin in the DP because
b-catenin signaling regulates HF growth and cycling (Enshell-
Seijffers et al., 2010; Kaushal et al., 2015; Tsai et al., 2014).
Epidermal b-catenin activation induces Blimp1 expression
and rescues the effect of dermal Blimp1 deletion
Because epidermal Wnt/b-catenin signaling is essential for
HF morphogenesis and anagen induction (Alonso and Fuchs
2003; Andl et al., 2002; Huelsken et al., 2001; Kobielak
et al., 2003; Myung et al., 2013), we examined whether
epidermal b-catenin activation would induce dermal Blimp1
expression in K14DNb-cateninER mice (Supplementary
Table S1, Supplementary Figure S6a, S6b online). Repeated
tamoxifen applications stimulate epidermis-derived GF
expression, including TGFb2, Shh, and FGF2, which induce
anagen, ectopic HF formation, and fibroblast proliferation
(Lichtenberger et al. 2016; Lo Celso et al. 2004). We found
that Blimp1 expression was induced in DPs of anagen and
ectopic HFs but not in other fibroblast subpopulations
(Supplementary Figure S6c).
To examine whether TGFb was required for Blimp1 in-
duction, we treated K14DNb-cateninER transgenic mice with
the TGFb inhibitor RepSox, which has previously been
shown to inhibit anagen and ectopic HF formation
(Lichtenberger et al. 2016). RepSox significantly inhibited
Blimp1 expression in ectopic DPs (Figure 6h, 6j). These ob-
servations were confirmed by inducing anagen in adult mice
by depilation. Treatment with RepSox led to a significant
reduction in Blimp1þ DP cells and reduction in HF growth
(Figure 6i, 6k, 6l).
To determine whether epidermal b-catenin activation
could rescue the HF growth defects induced by Blimp1 loss,
we crossed K14DNb-cateninER transgenics with
Blimp1(dKO) mice and neonates were treated with tamoxifen
(Supplementary Figure S6d, S6e). Epidermal b-catenin over-
expression overcame the reduction in HF length and dermal
thickness and increased fibroblast proliferation (Figure 6m,
6n, Supplementary Figure S6f, S6g).
To evaluate whether the delay in depilation-induced ana-
gen could also be overridden, mice were depilated and then
treated with 4OHT (Figure S6e, S6h). Epidermal b-catenin
activation accelerated anagen induction in both control and
Blimp1(dKO) mice without affecting HF density
(Supplementary Figure S6iek).
We conclude that epidermal b-catenin activation induces
Blimp1 expression in the DP via a TGFb signaling axis and is
able to overcome the dermal Blimp1 deletion defects in HF
morphogenesis and the postnatal HC.
DISCUSSION
We have explored the function of Blimp1 in dermal fibro-
blasts during postnatal development. Blimp1 is one of the
earliest dermal condensate markers and is rapidly down-
regulated at later stages of HF morphogenesis. Similarly,
during the postnatal HC, Blimp1 is highly expressed at ana-
gen initiation and downregulated subsequently. We specu-
late that dynamic Blimp1 expression in the DP is a
consequence of an autoregulatory feedback loop, whereby
Blimp1 represses its own expression, as shown in other tis-
sues (Mora-Lo´pez et al., 2007; Shaffer et al., 2002; Yan et al.,
2007; Figure 6o). Blimp1 expression in the hair matrix seems
to coincide with hair matrix cell differentiation; however, it is
unclear whether this is directly related to Blimp1 loss in the
DP. Blimp1 thus differs from other dermal condensate
markers such as Lef1 or Sox2, which are expressed
throughout morphogenesis (Figure 1b; Driskell et al., 2009).
Our data suggest that transient Blimp1 expression is
essential to promote core DP signals such as Wnt/b-catenin,
TGFb/BMP, and FGF during anagen entry and HF formation.
Indeed dermal Blimp1 deletion led to a delay in HF
morphogenesis and anagen onset as well as a failure of HF
neogenesis during wound healing. Zigzag HFs are the last to
form at the end of anagen, in the third HF wave, which might
explain why their size is most severely affected by the loss of
Blimp1. It has previously been reported that Sox2Cre-
mediated Blimp1 deletion leads to loss of the sensory
vibrissae with no obvious defect in pelage HFs (Robertson
et al., 2007), whereas in our studies, vibrissae formation
was only delayed (Supplementary Figure S1a). This is most
likely because Sox2Cre is active earlier in development (E6.5)
than Dermo1Cre (E12.5).
Lineage tracing experiments have shown that Blimp1
expressing cells give rise to cells of the papillary fibroblast
lineages, which undergo expansion in response to
epidermal b-catenin activation (Driskell et al. 2013;
Lichtenberger et al. 2016). However, prolonged
epidermal b-catenin activation fails to induce Blimp1
expression outside of the DP (Supplementary Figure S6c).
It seems likely that the increase in papillary dermis is due
to Blimp1 lineage expansion rather than expansion and
migration of Blimp1þ DP cells, because DP cells rarely
proliferate and do not exit the DP after wounding (Driskell
et al., 2013; Kaushal et al., 2015).
TGFb1 and TGFb2 are potent upstream regulators of
Blimp1 in dermal fibroblasts (Figure 6aec) and may poten-
tially act via the c-RAF to AP-1 pathway identified in breast
cancer cells (Romagnoli et al., 2012). TGFb/BMP family
members are strongly expressed in the DP and surrounding
epithelial cells during placode formation and HF anagen
induction (Jamora et al., 2005; Lyons et al., 1990; Oshimori
and Fuchs, 2012). Consistent with these observations,
treatment with the TGFb inhibitor RepSox inhibited Blimp1
expression in the DP (Figure 6hel). Because cultured fibro-
blasts expressed Blimp1 in response to TGFb, we suggest that
the lack of Blimp1 expression outside the DP is due to an
insufficient concentration of TGFb/BMP in the overlying
epidermis. We therefore propose a model where Blimp1
expression in the DP is induced by the TGFb/BMP signaling
axis through epithelial Wnt/b-catenin activation during the
telogen to anagen transition (Figure 6o).
Ingenuity Pathway Analysis indicated that b-catenin is
downregulated on Blimp1 ablation. In line with this, dermal
Blimp1 deletion led to a reduction in Wnt/b-catenin
signaling in the DP and papillary dermis (Figures 5gei and
6deg). This could reflect the lower number of papillary fi-
broblasts in Blimp1 mutants because papillary fibroblasts at
P2 are characterized by an active Wnt signaling signature
(Driskell et al., 2013; Rognoni et al., 2016). The failure of
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Figure 6. Blimp1 is induced by TGFb promoting, Wnt/b-catenin signaling in fibroblasts, and epidermal Wnt/b-catenin activation overcomes HF growth
defect after Blimp1 ablation. (a) Top 20 predicted upstream DP Blimp1 regulators by Ingenuity Pathway Analysis. (b, c) qPCR for Blimp1 after GF treatment of
(b) murine DP fibroblasts and (c) primary human fibroblasts. (deg) Blimp1 deletion impairs dermal Wnt/b-catenin signaling. (d) TOPGFP Control and
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wounds to regenerate HFs in the absence of Blimp1 might be
the combination of two defects: first, the reduction in
papillary fibroblasts and secondly inefficient epidermal Wnt/
b-catenin signaling induction in regenerating placodes and
HFs surrounding the wounds.
Blimp1 deletion not only affected HF growth but also HF
type and size, as observed after DP b-catenin ablation
(Enshell-Seijffers et al., 2010; Tsai et al., 2014). These find-
ings are consistent with our data indicating that Blimp1
positively regulates Wnt/b-catenin signaling. Because
epidermal b-catenin stabilization rescues the hair growth
defects resulting from Blimp1 deletion, we propose that
Blimp1 is a mediator of reciprocal Wnt signaling involving
the epidermis and dermis (Millar, 2002).
In summary, our results shed light on the previously
unrecognized role of Blimp1 in DP signaling initiation and
define its critical involvement in epidermal-mesenchymal
communication during HF initiation and regeneration.
MATERIALS AND METHODS
Mice
All experimental procedures were carried out under the terms of
a UK Home Office project license. All mice (Supplementary
Table S1) were maintained on a C57BL6/CBA background and
male and female mice were used in experiments. K14DNb-cat-
eninER mice were injected with 10 ml tamoxifen (50 mg/g body
weight, dissolved in corn oil) (Sigma-Aldrich/Merck, Darmstadt,
Germany) intraperitoneally at P0, followed by three topical ap-
plications of 4OHT (100 mg in acetone; Sigma-Aldrich). For
depilation experiments, four topical applications of 4OHT (100
mg in acetone) were made. To assess proliferation P11 mice were
injected intraperitoneally with 500 mg EdU in phosphate buffered
saline (Invitrogen/Thermo Fisher Scientific, Waltham, MA) 2
hours before isolation.
Neonatal wound healing was performed as described before
(Rognoni et al., 2016). Skin depilation was performed as described
(Sequeira et al., 2014) with adult (P56) telogen mice. For TGFb
inhibition, skin was treated with RepSox (1 mmol in acetone;
Tocris, Minneapolis, MN) daily before isolation.
Histology, microdissection, and microscopy
Human tissues were obtained with appropriate ethical approval
from the UK Human Developmental Biology Resource. Adult
surgical waste skin was obtained from the King’s Health Partners
Cancer Biobank (HTA Licence No: 12121, REC-No: 12-EE-0493).
Tissue samples were embedded in OCT and 12-mm cryosections
were processed following a standard protocol (Supplementary
Table S2 online). EdU incorporation was detected with the
Click-iT EdU-Alexa-Fluor555 kit (Thermo Fisher Scientific,
Waltham, MA). Wholemounts were processed as described pre-
viously (Rognoni et al., 2016). HF microdissection and sectioning
were performed as previously (Sequeira et al., 2014; Sequeira
and Nicolas, 2012). Imaging and processing were performed as
previously (Rognoni et al., 2016). Three skin sections from at
least three biological replicates per genotype were quantified.
FACS
Neonatal fibroblasts were isolated, labeled, and sorted or analyzed
as described previously (Driskell et al., 2013; Jensen et al., 2010).
Fibroblast culture
Mouse DP cells were sorted (EGFPþ, CD133þ, CD45, CD31,
CD324) and cultured in AmnioMaxC-100 with supplements
(Gibco) (37 C, 5%CO2). Human fibroblasts were cultured in
DMEMþ10% fetal bovine serum (Gibco/Thermo Fisher Scientific,
Waltham, MA). For GF screening, DP and human fibroblasts were
treated with the indicated GFs for 24 hours before mRNA isolation
(Supplementary Table S3 online).
mRNA isolation and qPCR
RNA was purified with the Purelink RNA microkit (Invitrogen) and
reverse transcribed with SuperScriptIII (Qiagen, Germantown, MD).
qPCRs were performed with RT2 Profiler PCR Arrays (Growth-Factor-
Array: PAMM-041ZE-1; Wnt-Signaling-Array: PAMM-243ZE-1) using
RT2-SYBR-Green-qPCR-Mastermix (Qiagen). Analysis was performed
by the delta-Ctmethod, using one-wayanalysis of variancewithGeisser-
Greenhouse correction and Holm-Sidak’s multiple comparisons test.
Bioinformatics
We compiled the pan-Blimp1 target gene signature by pooling pub-
lished RNA-seq and CHIP-seq data (Doody et al., 2010; Magnu´sdo´ttir
et al., 2007; Mould et al., 2015; Shaffer et al., 2002; Supplementary
Table S4 online) and generated the DP-specific signature by
analyzing the data from Greco et al. (2009), Hair-GEL (Sennett et al.,
2015) and our lab (Driskell et al., 2009; Supplementary Table S4). The
intersection between pan-Blimp1 target and DP lineage genes was
analyzed using the GSEA MGSig Database (Liberzon et al., 2011;
Subramanian et al., 2005) and the Ingenuity Pathway Analysis
(Supplementary Table S5 online, Figure 6a).
Quantification and statistical analysis
Statistical analyses were performed with GraphPad-Prism7. Unless
stated otherwise, statistical significance was determined by the un-
paired t-test for biological effects assuming a normal distribution (ns,
not significant, *P < 0.05, **P < 0.005, ***P < 0.0005). Icy software
spot-detector plugin was used for identification and quantification of
nuclei labeled with DAPI, Ki67, EdU, Blimp1, or TOPGFP.
For HF size, type, and thickness quantification, follicles were
randomly plucked from female adult telogen and P11 mice. For
whisker quantification, rows were microdissected and HF length
Blimp1(dKO) skin section immunostained for GFP and Itga6; (e) TOPGFPþ dermal cells were quantified. (f) TOPGFP FACS plots of total (upper panel) and DP
fibroblasts (lower panel) and (g) quantification. (h, i) TGFb signaling inhibition experimental protocols. (j) qPCR for Blimp1 in fibroblasts with and without
epidermal b-catenin activation. (k, l) TGFb signaling inhibition during depilation induced HF anagen. (k) Skin section immunostained for PDGFRa and Blimp1.
(l) Quantification of Blimp1þ DP cells (upper panel) and HF length (lower panel) 4 days after depilation. (m, n) Epidermal b-catenin activation during dermal
maturation. (m) Skin sections immunostained for Itga6 and Corin. (n) HF length (upper panel) and dermal thickness quantification (lower panel). (o) Model of
Blimp1 signaling during HF growth induction. We propose that during anagen induction epithelial Wnt/b-catenin signaling induces TGFb signaling, promoting
Blimp1 expression in the DP. Blimp1 activates Wnt/b-catenin signaling in the DP and stimulates proliferation of surrounding hair bulb cells, essential for
HF downgrowth. At a later anagen stage, Blimp1 expression in the DP is rapidly downregulated, presumably through self-inhibition (dotted line). Nuclei color
code: red, Blimp1þ; green, TOPGFPþ; yellow, Blimp1þ/TOPGFPþ; gray, unspecified. Data shown are means  standard deviation. *P < 0.05, **P < 0.005, ***P <
0.0005. Scale bars ¼ 100 mm. bcat, 4OHT-induced epidermal b-catenin; Blimp1, B-lymphocyte-induced maturation protein 1; BW, body weight; DP, dermal papilla;
HF, hair follicle; IP, intraperitoneal injection; ns, not significant; PD, postdepilation; qPCR, quantitative PCR; TGFb, transforming growth factor-b.
=
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was measured from DP to skin surface. To quantitate new HFs in
wounds, at least eight 60-mm sections per wound were analyzed.
Dermal, Ki67þ, Blimp1þ DP, and TOPGFPþ cell densities were
quantified from at least eight 12-mm skin section or 60-mm hori-
zontal wholemounts per genotype.
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